Filing Details
- Accession Number:
- 0001127602-24-009989
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-13 16:31:57
- Reporting Period:
- 2024-03-12
- Accepted Time:
- 2024-03-13 16:31:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 97745 | Thermo Fisher Scientific Inc. | TMO | Measuring & Controlling Devices, Nec (3829) | 042209186 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1676320 | P. Lisa Britt | 168 Third Avenue Waltham MA 02451 | Sr. Vp And Chief Hr Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-03-12 | 8,445 | $190.59 | 25,768 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-03-12 | 8,445 | $598.90 | 17,323 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-03-12 | 5,900 | $210.68 | 23,223 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-03-12 | 5,900 | $598.90 | 17,323 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-03-12 | 8,445 | $0.00 | 8,445 | $190.59 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-03-12 | 5,900 | $0.00 | 5,900 | $210.68 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2021-03-07 | 2024-09-07 | No | 4 | M | Direct |
| 0 | 2025-02-27 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2023.
- The option vested in four equal installments on February 27, 2019, 2020, 2021, and 2022.
Billionaire Hedge Funds
